Dr. Ashok Kumar, President – Research and Development (Chemical) at IPCA...
Dr. Ashok Kumar PRESIDENT – R&D (Chemical) at IPCA LABORATORIES LTD LINKS https://in.linkedin.com/pub/ashok-kumar/16/6a7/903 Intro The 25-year process patent regime allowed a large number of...
View ArticleRegulation of Herbal (Traditional) Medicinal Products in the European Union
Regulation of Herbal (Traditional) Medicinal Products in the European Union Introduction The European Union (EU) regulatory framework for medicinal products is complex and is based on the need of...
View ArticleIPI 504, Retaspamycin, Retaspimycin
IPI 504, Retaspamycin, Retaspimycin CAS 857402-63-2 Cas 857402-23-4 ( Retaspimycin); 857402-63-2 ( Retaspimycin HCl). MF C31H45N3O8 BASE MW: 587.32067 BASE Infinity Pharmaceuticals Inc, INNOVATOR...
View ArticleNew “mTOR” inhibitor from Exelixis, Inc., XL 388
XL 388 A Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR) Benzoxazepine-Containing Kinase Inhibitor...
View ArticleWhat are “complex manufacturing processes”? A recent reply from the EMA
Originally posted on DRUG REGULATORY AFFAIRS INTERNATIONAL: Sometimes a clear definition of terms is crucial in the communication between authorities and pharmaceutical companies. Find out what the...
View ArticleStudy Demonstrates Efficacy of New Tumor Treatment
Study Demonstrates Efficacy of New Tumor Treatment The results of a study demonstrate the efficacy of this drug in treating nonfunctional neuroendocrine tumors of lung or gastrointestinal origin. FULL...
View ArticleTRAMADOL
2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Tramadol (marketed as Ultram, and as generics) is an opioid pain medication used to treat moderate to moderately severepain.[1] When taken...
View ArticleGSK 2251052, Epetraborole, AN3365
(S)-3-(Aminomethyl)-7-(3-hydroxypropoxy)-1-hydroxy-1,3-dihydro- 2,1-benzoxaborole (GSK2251052) is a novel boron-containing antibiotic that inhibits bacterial leucyl tRNA synthetase, and that has been...
View Articleкрисаборол , كريسابورول , Crisaborole, AN 2728
Crisaborole Treatment for Inflammatory Skin Diseases, including Atopic Dermatitis and Psoriasis C14H10BNO3, Average mass251.045 Da 4-[(1-Hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy]benzonitrile ,...
View ArticleFDA Says Chinese Pfizer Plant Hid Failures, Used Old Ingredients
Originally posted on DRUG REGULATORY AFFAIRS INTERNATIONAL: October 31, 2015 — 2:22 AM IST, The Pfizer Ltd. research and development plant in Dalian, China. Bernardo De Niz/Bloomberg A Pfizer Inc....
View ArticleSERTINDOLE
. SERTINDOLE Sertindole (brand names: Serdolect, and Serlect) is an antipsychotic medication. Sertindole was developed by the Danish pharmaceutical company H. Lundbeck and marketed under license by...
View ArticleSCYX 7158
SCYX-7158 SCYX-7158 [4-fluoro-N-(1-hydroxy-3,3-dimethyl-1,3-dihydro-benzo[c]oxaborol-6-yl-2-trifluoromethyl benzamide]...
View ArticleCEP 18770, Delanzomib
CEP-18770, Delanzomib cas 847499-27-8 Chemical Formula: C21H28BN3O5 Exact Mass: 413.21220, UNII-6IF28942WO;...
View ArticleSILICO LINEZOLID
Therapeutic options for brain infections caused by pathogens with a reduced sensitivity to drugs are limited. Recent reports on the potential use of linezolid in treating brain infections prompted us...
View ArticleNew route for Expensive drug Ivacaftor synthesis from CSIR-NCL, Pune, India
IVACAFTOR Breaking and Making of Rings: A Method for the Preparation of 4-Quinolone-3-carboxylic Acid Amides and the Expensive Drug Ivacaftor N. Vasudevan†, Gorakhnath R. Jachak† and D. Srinivasa...
View ArticleGKM 001 in pipeline for Diabetes by Advinus
GKM 001……Several probables Watch out on this post as I get to correct structure……….. Advinus Therapeutics Private L, A glucokinase activator for treatment of type II diabetes Company Advinus...
View ArticleZYDPLA 1 From ZYDUS CADILA, a new NCE in Gliptin class of antidiabetic agents.
GENERAL STRUCTURE ZYDPLA 1……….Probable Representative structure only, I will modify it as per available info Cadila Healthcare Limited ZYDPLA1 is an orally active, small molecule NCE, discovered and...
View ArticleDC_AC50, selective way of blocking copper transport in cancer cells
DC_AC50 3-amino-N-(2-bromo-4,6-difluorophenyl)-6,7-dihydro-5H- cyclopenta [b] thieno [3,2-e] pyridine-2-carboxamide licensed DC_AC50 to Suring Therapeutics, in Suzhou, China INNOVATORS Jing Chen...
View ArticleZydus Cadila’s new 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine...
List of compounds as DPP-IV inhibitors Watch out on this post as I get to correct structure……….. 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds One Example of...
View Article